Company: MBIO
Filing Date: 2025-04-04
Form Type: POS AM
Source: 0001104659-25-032236
Chunk: 24

Company: MUSTANG BIO, INC.
Filing Date: 2025-04-04
Form: POS AM
Chunk 24
---
 matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question
whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication
of such issue.

<div align='center'>26

SIGNATURES</div>

Pursuant to the requirements of the Securities
Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly
authorized in the City of Waltham, Commonwealth of Massachusetts, on April 4, 2025.

| Mustang Bio, Inc. |                                                  |
| By:               | /s/ Manuel Litchman, M.D.                        |
|                   | Manuel Litchman, M.D.                            |
|                   | Chief Executive Officer, Interim Chief Financial 
 Officer and President                            |

Pursuant to the requirements of the Securities
Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature                  
 /s/ Manuel Litchman, M.D.  
 Manuel Litchman, M.D.      |     | Title                                                                            
 President, Chief Executive Officer, Interim Chief Financial Officer and Director 
 (Principal Executive Officer and Principal Financial and Accounting Officer)     |     | Date          
 April 4, 2025 |
|:---------------------------|:----|:---------------------------------------------------------------------------------|:----|:--------------|
| *                          |     | Chairman of the Board of Directors and Executive Chairman                        |     |               |
| Michael S. Weiss           |     |                                                                                  |     | April 4, 2025 |
| *                          |     |                                                                                  |     |               |
| Adam Chill                 |     | Director                                                                         |     | April 4, 2025 |
| *                          |     |                                                                                  |     |               |
| Neil Herskowitz            |     | Director                                                                         |     | April 4, 2025 |
| *                          |     |                                                                                  |     |               |
| David Jin                  |     | Director                                                                         |     | April 4, 2025 |
| *                          |     |                                                                                  |     |               |
| Lindsay A. Rosenwald, M.D. |     | Director                                                                         |     | April 4, 2025 |
| *                          |     |                                                                                  |     |               |
| Michael Zelefsky, M.D.     |     | Director                                                                         |     | April